Physician profile
Dorian D Lain
NPI 1356371223
$3,609.38
in general payments reported to CMS, 2019-2025
16 companies · $1,134 in 2025
The $1,134 reported for 2025 was more than what 92% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $89.39 · 2020: $155 · 2021: $403 · 2022: $497 · 2023: $504 · 2024: $828 · 2025: $1,134.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,458 · Education: $7.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,457.83 |
| Education | $7.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $591.68 | 2023-2025 | Miebo, Xiidra, Infuse |
| Tarsus Pharmaceuticals, INC. | $585.10 | 2024-2025 | Xdemvy |
| Mallinckrodt Hospital Products INC. | $453.57 | 2021-2023 | Acthar |
| Alcon Vision LLC | $393.30 | 2019-2025 | Tryptyr, Eysuvis, Precision 1 |
| Oyster Point Pharma, INC. | $367.59 | 2022-2025 | Tyrvaya |
| Novartis Pharmaceuticals Corporation | $338.14 | 2019-2023 | |
| Sun Pharmaceutical Industries INC. | $272.70 | 2022-2025 | Cequa |
| Abbvie INC. | $200.95 | 2022-2025 | |
| Allergan, INC. | $131.35 | 2020-2022 | |
| Johnson & Johnson Vision Care, INC. | $110.06 | 2020-2025 | Acuvue |
| Dompe US, INC. | $53.19 | 2024-2025 | Oxervate |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $35.16 | 2019 | |
| Coopervision INC. | $24.74 | 2019 | |
| Horizon Therapeutics Plc | $17.97 | 2021 | |
| Biotissue Holdings INC. | $17.76 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $16.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dorian Lain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.